MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes.

MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes.
复制标题

DOI:
10.1371/journal.pone.0116067
复制
发表时间:
2015
期刊:
影响因子:
3.7
通讯作者:
Lv H
Lv H
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Bao L;Fu X;Si M;Wang Y;Ma R;Ren X;Lv H

文献摘要

参考文献

被引文献

相似文献

糖尿病是最常见和最复杂的代谢紊乱,是当今最重要的健康威胁之一。MicroRNA(miRNAs)是一类小的非编码RNA,在葡萄糖稳态等多种生理过程中发挥重要作用。在这项研究中,我们研究了miR-185在糖尿病中的作用。miR-185在糖尿病患者和小鼠中显著下调,且低水平与血糖浓度相关。过表达miR-185可促进胰岛β细胞胰岛素分泌,促进细胞增殖,保护细胞免于凋亡。使用计算机模拟预测、荧光素酶报告基因测定和蛋白质印迹测定的进一步实验证明,miR-185通过结合其3 '-UTR直接靶向SOCS 3。与miR-185的保护作用相反,SOCS 3显著抑制β细胞的功能并灭活Stat 3通路。当用miR-185模拟物与SOCS 3过表达质粒组合处理细胞时,SOCS 3的抑制作用被逆转。而与单独的miR-185模拟物或SOCS 3 siRNA处理相比,miR-185模拟物和SOCS 3 siRNA的组合处理诱导协同促进作用。此外,我们观察到糖尿病患者中miR-185水平与SOCS 3表达呈负相关。总之,这项研究揭示了miR-185和SOCS 3在糖尿病发病机制中的功能和机制联系。MiR-185在糖尿病胰岛素分泌和β细胞生长的调节中起重要作用。miR-185表达的恢复可能为糖尿病提供一种潜在的有前景和有效的治疗方法。
Diabetes is the most common and complex metabolic disorder, and one of the most important health threats now. MicroRNAs (miRNAs) are a group of small non-coding RNAs that have been suggested to play a vital role in a variety of physiological processes, including glucose homeostasis. In this study, we investigated the role of miR-185 in diabetes. MiR-185 was significantly downregulated in diabetic patients and mice, and the low level was correlated to blood glucose concentration. Overexpression of miR-185 enhanced insulin secretion of pancreatic β-cells, promoted cell proliferation and protected cells from apoptosis. Further experiments using in silico prediction, luciferase reporter assay and western blot assay demonstrated that miR-185 directly targeted SOCS3 by binding to its 3’-UTR. On the contrary to miR-185’s protective effects, SOCS3 significantly suppressed functions of β-cell and inactivated Stat3 pathway. When treating cells with miR-185 mimics in combination with SOCS3 overexpression plasmid, the inhibitory effects of SOCS3 were reversed. While combined treatment of miR-185 mimics and SOCS3 siRNA induced synergistically promotive effects compared to either miR-185 mimics or SOCS3 siRNA treatment alone. Moreover, we observed that miR-185 level was inversely correlated with SOCS3 expression in diabetes patients. In conclusion, this study revealed a functional and mechanistic link between miR-185 and SOCS3 in the pathogenesis of diabetes. MiR-185 plays an important role in the regulation of insulin secretion and β-cell growth in diabetes. Restoration of miR-185 expression may serve a potentially promising and efficient therapeutic approach for diabetes.
DOI: 10.1016/s0140-6736(14)60613-9
发表时间: 2014-06-07
期刊: Lancet (London, England)
影响因子: --
作者:
Ley SH;Hamdy O;Mohan V;Hu FB
通讯作者: Hu FB
DOI: 10.1016/j.freeradbiomed.2013.06.009
发表时间: 2013-09
影响因子: 7.4
作者:
Kato, Mitsuo;Castro, Nancy E.;Natarajan, Rama
通讯作者: Natarajan, Rama
DOI: 10.1515/bc.2008.026
发表时间: 2008-03-01
影响因子: 3.7
作者:
Lovis, Pascal;Gattesco, Sonia;Regazzi, Romano
通讯作者: Regazzi, Romano
DOI: 10.1038/onc.2010.233
发表时间: 2010-09-01
期刊: ONCOGENE
影响因子: 8
作者:
Imam, J. S.;Buddavarapu, K.;Rao, M. K.
通讯作者: Rao, M. K.
DOI: 10.1074/jbc.m601225200
发表时间: 2006-09-15
影响因子: 4.8
作者:
Plaisance, Valerie;Abderrahmani, Amar;Regazzi, Romano
通讯作者: Regazzi, Romano